1 not yet recruiting, 1 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Withdrawn 1 |
Follow αDC1 Vaccine: new trials by email Literature Review of αDC1 Vaccine trials Research Report on αDC1 Vaccine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer Paclitaxel, Cisplatin, Bioferon - Ovarian Cancer | Phase 2 | Not yet recruiting | Kalinski, Pawel, MD, PhD | 28 | 2026-10-01 | 2026-10-13 |
| A Study of Type-1 Polarized Dendritic Cell (αDC1) Vaccine in Combination With Tumor-Selective Chemokine Modulation (Interferon-α2b, Rintatolimod, and Celecoxib) in Subjects With Chemo-Refractory Metastatic Colorectal Cancer αDC1 vaccine, CKM - Metastatic Colorectal Cancer | Phase 2 | Withdrawn | Pawel Kalinski | 2016-03-01 | 2017-09-26 |
Colorectal Neoplasms (1) · Ovarian Neoplasms (1)
Kalinski, Pawel, MD, PhD (1) · Pawel Kalinski (1)
United States (2)
James J Lee, MD, PhD (1) · Robert Edwards, MD (1)